Baxter Vaccines continues to look to the future, with its state-of-the-art research centers in Austria dedicated to the prevention of a broad spectrum of infectious disease in infants, children and adults. Currently we have two products on the market: our TBE vaccine and a vaccine against group C meningococcal meningitis.

Baxter International Inc. is a global health care company that, through its subsidiaries, provides critical therapies for people with life-threatening conditions. Baxter’s Bioscience, Medication Delivery and Renal products and services are used to treat patients with some of the most challenging medical conditions including cancer, hemophilia, immuno deficiencies, infectious diseases, kidney disease and trauma. With 2004 sales of $9.5 billion, and approximately 47,000 team members, Baxter is a global leader in developing innovative medical therapies that improve the quality of life for people around the world.

 » Printversion